COMMUNIQUÉS West-GlobeNewswire

Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
29/11/2018
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Geron to Host Analyst and Investor Event on December 10, 2018
28/11/2018
MENLO PARK, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that the Company’s analyst and investor event will take place in New York, N.Y., on Monday, December 10, 2018. [...]
Radient Technologies Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update
28/11/2018
EDMONTON, Alberta, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) announced today that it has released its financial results for the second fiscal quarter [...]
Imagin Medical Comments on Recent Promotional Activity Pursuant to OTC Markets Request
28/11/2018
VANCOUVER, British Columbia and BOSTON, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) wishes to make the following [...]
Retrophin to Present at the BMO Prescriptions for Success Healthcare Conference
28/11/2018
SAN DIEGO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Stephen Aselage, chief executive officer, will present at the BMO 2018 Prescriptions for Success Healthcare Conference in [...]
Oasmia intends to issue notice to an extraordinary general meeting at the request of a shareholder and announces that it is subject to legal proceedings with a major shareholder concerning the company’s warrants 2018/2019
28/11/2018
Oasmia Pharmaceutical AB (publ) (“Oasmia”) hereby announces that Oasmia’s largest shareholder, Arwidsro Investment AB and Per Arwidson (together “Arwidsro”), on the basis of Chapter 7 Section 13 of the Swedish Companies [...]
Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability
28/11/2018
Almost 90% ocular delivery success with high-precision smart micro-dosing sets new benchmark for topical instillation to the eye NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) today announced [...]
Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results
28/11/2018
- TransCon CNP preliminary phase 1 data support target product profile and further validates TransCon ™ technology - - Diversified pipeline with three independent, clinically-validated rare disease endocrinology product [...]
Ascendis Pharma A/S Announces Positive Preliminary Phase 1 Data for TransCon CNP
28/11/2018
- TransCon CNP delivered continuous exposure of CNP at target levels for seven days with a single subcutaneous administration - - TransCon CNP phase 1 results reinforce preclinical data and support target product [...]
Novitium Pharma Launches Ranitidine Capsules
28/11/2018
EAST WINDSOR, N.J., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Novitium Pharma LLC is pleased to announce that it has received U.S. Food and Drug Administration approval on its Abbreviated New Drug Application (“ANDA”) for [...]
NeuroMetrix to Present at the LD Micro 11th Annual Main Event on December 5, 2018
28/11/2018
WALTHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix, is scheduled to speak at the upcoming LD Micro Annual [...]
Loma Linda Patient First in California to Receive a Telescope Implant for Macular Degeneration after Having Cataract Surgery
28/11/2018
Surgery Part of a National Clinical Trial LOMA LINDA, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- A patient at Loma Linda University Eye Institute became the first in California to receive the Miniature Implantable [...]
Sharecare named to Deloitte 2018 Technology Fast 500™ for second consecutive year
28/11/2018
ATLANTA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company that helps people manage all their health in one place, today announced it was recognized on Deloitte’s Technology Fast 500™, a ranking of [...]
Weekend Unlimited Commences Construction of BC Greenhouses -- CFN Media
28/11/2018
SEATTLE, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Phoenix Life Sciences International Announces Angus Stewart as Company’s New Agriculture and Horticulture Senior Advisor
28/11/2018
DENVER, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Angus Stewart has joined [...]
Terra Tech Corporation to Present at the 11th Annual LD Micro Main Event on December 5th
28/11/2018
IRVINE, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, today announced that its Chief Executive [...]
Medifirst Solutions Finalizes Relationship With Dr. Gupta Pharma
28/11/2018
Freehold, NJ, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
28/11/2018
New evidence supporting the benefit of selective BET inhibition in the treatment of cardiovascular disease, chronic kidney disease and neurodegenerative disease CALGARY, Alberta, Nov. 28, 2018 (GLOBE NEWSWIRE) -- [...]
SELLAS Life Sciences Announces Expedited Development Path for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Following Feedback from FDA
28/11/2018
Agreement on new open-label randomized registrational Phase 3 study in patients in second complete remission (CR2) poised to reduce sample size, time to primary endpoint and costs Fast-Track and Orphan Drug designations [...]

Pages